We Rang the Bell!
What a great weekend! We had our third BellRinger ride on Saturday.
By the numbers it was a great success:
- At least 1,166 Riders — over 200 more than last year
- 70 Virtual Riders
- 391 Volunteers
- 419 Student Riders
- 151 Teams
- $4.28 million raised since 2022 (and counting — money for this year’s ride will roll in through December 31)
However, the numbers only tell part of the story. The impact on our cancer research will be huge. Read more.
| |
Lombardi Lectures & Meetings | |
Join these lectures in the New Research Building Auditorium (Zoom option). | |
Georgetown Lombardi Faculty Meeting TODAY | |
BellRinger Weekend Finishes Strong | |
|
Dr. Norman Beauchamp Jr., EVP for Health Sciences at GUMC, spoke at the Opening Ceremony for BellRinger. | |
BellRinger riders paused at the starting line for the singing of the national anthem. | |
More than a thousand riders took to the roads (in person and virtually) this past weekend for the Third Annual BellRinger. Thanks to their efforts, the total all-time funds raised by BellRinger in support of cancer research and clinical trials at Georgetown Lombardi now top $4.2 million. Thank you to all who participated as riders, volunteers and supporters! | |
Community Outreach and Engagement Leadership Changes | |
Georgetown Lombardi leadership is pleased to announce changes in our leadership structure to reflect our expanding work in the communities we serve. Chiranjeev Dash, PhD, MBBS, will now serve as Associate Director for Community Outreach and Engagement, and Lisa Carter-Bawa, PhD, MPH, APRN, ANP-C, FAAN, will serve as Deputy Associate Director for Community Outreach and Engagement. Over the last few years, both Dash and Lisa have demonstrated effective vision and leadership in this space and we anticipate that with these appointments, they'll work together to expand their reach.
These changes allow Lucile Adams-Campbell, PhD, who had served in the COE role, to double down on her role as Associate Director for Minority Health and Health Disparities Research. The Cancer Prevention and Control Program will continue to be co-led by Laura Rozek, PhD, and Kenneth Tercyak, PhD. Dr. Carter-Bawa will remain actively engaged in the program through membership on the steering committee but will no longer serve as a co-leader.
| |
|
Robbins Selected to Receive Project Cure CRC Award | |
David Robbins, PhD, Cancer Cell Biology Program co-leader, was one of five new awardees selected to receive funding from Project Cure CRC, a fund underwritten by the nonprofit Colorectal Cancer Alliance. The award will support Robbins’ research into ways to stop colorectal cancer from spreading by targeting circulating tumor cells, the cells responsible for forming new tumors in other parts of the body.
| |
Seeking Cancer Use Cases and Collaborators for ARPH-H Project | |
ICBI recently received a subaward to participate in the ARPA-H Biomedical Data Fabric (BDF) initiative, which seeks to create tools to integrate biomedical research data from multiple sources and enhance its usefulness. ICBI is part of the funded project “DNA HIVE Federated Learning Network”; ICBI Director Peter McGarvey, PhD, is the site principal investigator. This initiative seeks to develop infrastructure and tools that enable secure federated queries and analysis of cancer health records without the data leaving the institution. It will leverage omnichannel data sources to investigate disease complexity and outcomes.
ICBI is seeking research investigators to engage in cancer use cases (application examples/ scenarios) and propose research studies that can span the DNA HIVE network. Those who are interested are invited to complete this short form.
| |
NCI Early K99/R00 Pre-applications Now Accepted
Pre-applications are now being accepted for the NCI Early K99/R00. Candidates must be within two years of their doctoral degree at grant submission and in a mentored postdoctoral position. Nominations will identify single applicants within the described four scientific areas and submit pre-application materials by November 15 for the February 15, 2025, deadline within GU-PASS as a New Limited Submission; select 2025 NCI Pathway to Independence for Early Stage Postdocs (K99/R00). Email Richard Cecil (rc398@georgetown.edu) with questions.
| |
Fall 2024 Faculty Appointment and Promotions Workshops
-
SOM Clinical and Biomedical Tracks: Wednesday, October 30, 12:00 - 1:00 p.m.: RSVP
-
Adjunct Track: Wednesday, November 6, 12:00 - 1:00 p.m.: RSVP
| |
2024 Luminary Awards in GI Cancers
Join the Ruesch Center for this year’s Luminary Awards in GI Cancer on Thursday, Nov. 21, at the Westin Georgetown, Washington, D.C., from 6:00 to 8:30 p.m. The Luminary Awards honors individuals who have made transformative strides in the lives of patients with Gastrointestinal Cancers. Learn more about this year’s honorees. For questions or to register, email rueschcenter@georgetown.edu.
| |
15th Annual Ruesch Center Symposium: Innovations in GI Cancer | |
Registration is now open for the 15th Annual Ruesch Center Symposium: Innovations in GI Cancer, held in person this November 22 to 23 at the Westin Georgetown. The symposium provides a unique forum for discussion, networking, and debate on critical issues related to GI cancers.
| |
Presented as part of the symposium: Thomas R. Schafer Memorial Lecture, Friday, November 22, 1:20 - 2:20 p.m., featuring Anirban Maitra, MBBS, of the University of Texas MD Anderson Cancer Center presenting “Why Is Pancreatic Cancer So Hard To Treat and What Can We Do About It.”
Registration is free for Georgetown and MedStar staff and trainees with the promo code Guest2024. View the full agenda and register.
| |
Each year, the MedStar Health-Georgetown University Research & Education Symposium brings together investigators, educators, executive leaders, associates and collaborative partners from across our academic health system to share research, build meaningful relationships, and advance health for our communities. Please mark your calendars to attend this celebration of research and education across our academic health system partnership on Monday, May 19, 2025, at the North Bethesda Marriott. A call for abstract submissions will be announced this fall.
| |
Georgetown Lombardi DEI Updates | |
This Friday: Tackle Unfinished Writing Tasks at a Free Writing Retreat | |
Meetings & Events This Week | |
Meetings & Events Next Week | |
12:00 - 1:00 p.m.
Oncology Grand Rounds Series
Presented by Daniela Quail, PhD, assistant professor, Rosalind and Morris Goodman Cancer Institute, Department of Physiology, Faculty of Medicine and Health Sciences, McGill University. Join this Grand Rounds in the New Research Building Auditorium or via Zoom. (Add to Google Calendar)
| |
Funding and Award Opportunities | |
FINAL WEEK: Request for Applications — American Cancer Society Institutional Research Grant Pilot Project Grants | |
| | Up to three American Cancer Society Institutional Research Grant (IRG) Pilot Project Grants will be funded to help launch promising new projects by early career faculty members. These are one-year, non-renewable $30,000 research grants that are funded through Georgetown Lombardi’s IRG, which is sponsored by the American Cancer Society. Open to early career faculty (e.g. assistant professor or equivalent), who are eligible to apply for independent national competitive research grants (e.g. NIH R-level grants, ACS Research Scholar Grants, and similar), but who do not currently hold and have not previously held such a grant, with the exception of an R00, which is allowed. View application package with full eligibility criteria, application form, and mentoring requirements. Application deadline: Monday, November 4, at 11:59 p.m. For scientific or eligibility questions, contact Dr. Rebecca Riggins (PI of the ACS IRG), rbr7@georgetown.edu. For application download or upload questions, contact Denise Harley, flessatd@georgetown.edu, or Karen Howenstein, khowenst@georgetown.edu.
| |
Melanoma Research Alliance RFP for Multiple Awards
The Melanoma Research Alliance has issued a request for proposals for preclinical, translational and early clinical research with the potential to produce unusually high impact, near-term advancements in melanoma prevention, detection, diagnosis and treatment.
This cycle, proposals will be accepted for Established Investigator Awards, Academic-Industry Partnership Award (for Established Investigator Awards), Young Investigator Awards, Pilot Awards, Dermatology Career Development Awards and Special Opportunity Team Science Awards, Academic-Industry Partnership Award (for Special Opportunity Team Science Awards). View full descriptions of each award opportunity offered, including all Special Opportunities, as well as eligibility criteria and instructions.
Key deadlines:
-
November 4: Proposals for Established Investigator, Young Investigator, Pilot and Dermatology Career Development awards due
-
January 6: Invited Special Opportunity Team Science Award full proposals due
-
April 2025: Awardees notified of funding decisions
| |
St. Baldrick’s Foundation Spring Grant Cycle
The following programs/categories are available in the Spring Cycle:
One LOI/application can be submitted per award per institution, with an exception for the following areas: brain tumors – all types, including rare forms; Burkitt lymphoma (all types, especially sporadic); Ewing sarcoma; rhabdoid tumors – extrarenal. Those interested should send the title of their project and a one-paragraph synopsis to Sharon Levy via email (sgl5@georgetown.edu) by Sunday, Dec. 1.
| |
Federal Grants Digest: Colleges & Universities Edition
A weekly curated digest of federal funding opportunities of interest to colleges and universities to support programming, research, infrastructure and other efforts, provided by Thorn Run Partners. View current issue (for October 23, 2024).
| |
Tumor Board & Research Meeting Schedule | |
Meetings in italics should be attended by all fellows.
| |
8:00 AM | Division Weekly Update Meeting | Podium A / Microsoft Teams
8:30 AM | Monday Morning Oncology Report | Inpatient Oncology Fellow | Podium A / Microsoft Teams
9:00 AM | Breast Research Meeting | Podium A / Zoom (dial 646-558-8656; Meeting ID: 528 212 194)
11:00 AM | GU/Melanoma Research Meeting | Podium A / Zoom (dial 646-558-8656; Meeting ID: 796 253 566)
4:00 PM | GU Tumor Board (on 1st/3rd Mondays of the month) | Podium A / Zoom (dial 646-558-8656; Meeting ID: 869 742 463)
| |
9:00 AM | Hematology Path Conference - Inpatient Heme fellows + Outpatient Heme + BMT fellow | Podium A / Microsoft Teams (CME code: 80737; phone: 202-796-7323)
4:00 PM | Liver Tumor Board | Microsoft Teams
5:00 PM | Breast Tumor Board | Podium A / Zoom (dial 646-558-8656; Meeting ID: 932 1012 3816; CME Code: 87253)
| |
8:00 AM | Thoracic Tumor Board | Podium A / Zoom (dial 646-558-8656; Meeting ID: 993 7680 5192; Passcode: 4231; CME 86693)
12:00 PM | Melanoma Tumor Board | Podium A / Microsoft Teams (CME: 80988)
5:00 PM | GI Tumor Board | Podium A / Microsoft Teams
| |
9:00 AM | Cancer Research Data Meeting | Rachael Maynard | W302 New Research Building or Zoom
9:30 AM | Head and Neck Tumor Board | Microsoft Teams
12:30 PM | GI Research Meeting | WebEx (dial 844-302-0362, Meeting Number (access code): 712527865, HOST PIN: 5514)
5:00 PM | Lymphoma Tumor Board - every other week | Microsoft Teams
5:00 PM | Myeloma Tumor Board - every other week | Microsoft Teams
| |
7:00 AM | CNS Tumor Board | Microsoft Teams (Meeting ID: 298 285 483 265, Passcode: rJWpmU)
12:00 PM | Oncology Grand Rounds | David Scadden, MD: “The Adult Thymus and Cancer Risk” | New Research Building Auditorium / Zoom
12:00 PM | TBA | Podium A | Teams Conference Link (Text In Code: 81202 or 81203 / Text In Telephone: 202-796-7323)
1:00 PM | TBA | Podium A | Teams Conference Link (Text In Code: 81202 or 81203 / Text In Telephone: 202-796-7323)
1:00 PM | Pancreas Tumor Board | Microsoft Teams (Meeting ID: 299 996 740 910, Passcode: z7j7Rc)
2:00 PM | TBA | Podium A | Teams Conference Link (Text In Code: 81202 or 81203 / Text In Telephone: 202-796-7323)
| |
Connect with Georgetown Lombardi on Social Media | |
If you would like to share news or updates from your department, please get in touch with Sarah Riehl.
| | | | |